Standardization of cytokine flow cytometry assays
Holden T. Maecker(Stanford University), Rafick‐Pierre Sékaly(University Hospitals of Cleveland), Miguel Garcia(Centre Hospitalier Universitaire Vaudois), Aline Rinfret(Université de Montréal), Giuseppe Pantaleo(University of Lausanne), Kara Punt(United States Military Academy), Ruth Baydo(University of Washington), Nolwenn Nougarede(Sanofi (France)), Barry M. Bredt(San Francisco General Hospital), Sandra A. Calarota(University of Pennsylvania), Josephine Birungi(Uganda Virus Research Institute), Claire Landry(Université de Montréal), Richard A. Koup(Aaron Diamond AIDS Research Center), Kent J. Weinhold(Duke Medical Center), Janet Ottinger(Duke Medical Center), Alexandre Harari(University Hospital of Lausanne), Marcus Altfeld(Harvard University), C. Lorrie Epling(University of California, San Francisco), Clive M. Gray(National Center for Communicable Diseases), G Alter(Boston University), Ellen Kuta(Jackson Foundation), Lynda Tussey(United States Military Academy), Peter Hayes(International AIDS Vaccine Initiative), Laurie Lamoreaux(University of Washington), Ian Frank(Norwegian Womens Public Health Association), Janice M. Darden(Henry M. Jackson Foundation), Timothy W. Tobery(Unilever (Netherlands)), Jean Boyer(University of Pennsylvania), Jennifer Holbrook(Nemours Children’s Clinic), Sophia El-Bahi(Sanofi (France)), Jill Gilmour(International AIDS Vaccine Initiative), Josephine H. Cox(International AIDS Vaccine Initiative), Maria Suni(BD Biosciences (United States)), Mario Roederer(National Institutes of Health), Omu Anzala(International AIDS Vaccine Initiative), Helen Horton(New York Blood Center), Patricia D’Souza(National Institutes of Health), Eva Roig(Université de Montréal), Megan Baker, Elizabeth Sinclair(San Francisco General Hospital), Vernon C. Maino(BD Biosciences (United States)), Hazel Maila(National Center for Communicable Diseases)
Cited by 240
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k